Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease

Published:2021-12-19 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kramer Jennifer R.¹²^ORCID,Natarajan Yamini¹³^ORCID,Dai Jianliang⁴,Yu Xian¹,Li Liang⁴,El‐Serag Hashem B.³^ORCID,Kanwal Fasiha¹³^ORCID

Affiliation:

1. Center for Innovations in Quality, Effectiveness and Safety (IQuESt) Michael E. DeBakey Veterans Affairs Medical Center Houston Texas USA

2. Section of Health Services Research Department of Medicine Baylor College of Medicine Houston Texas USA

3. Section of Gastroenterology and Hepatology Department of Medicine Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center Houston Texas USA

4. Department of Biostatistics University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

Health Services Research and Development

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Cancer Prevention and Research Institute of Texas

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32244

Reference35 articles.

1. Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

2. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

3. Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults With Type 2 Diabetes

4. Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

5. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated steatotic liver disease and its link to cancer;Metabolism;2024-11

2. Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes;Alimentary Pharmacology & Therapeutics;2024-09-10

3. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

4. Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologist;Expert Review of Gastroenterology & Hepatology;2024-08-02

5. Metformin as adjuvant treatment in hepatitis C virus infections and associated complications;The American Journal of the Medical Sciences;2024-08